Results 11 to 20 of about 43,771 (194)

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015

open access: yesVaccines, 2022
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal   +12 more
doaj   +1 more source

Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines

open access: yesMathematical Biosciences and Engineering, 2019
The only rubella vaccine available in North America is the RA27/3 strain (isolated from the kidney of a rubella-infected fetus and attenuated) licensed in 1979, which substituted HPV77/DE5 strain vaccine due to concerns about waning immunity.
Hyun Mo Yang   +1 more
doaj   +1 more source

Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal [PDF]

open access: yes, 2018
Although most countries in the WHO European Region were verified in 2017 as having interrupted endemic measles transmission, nine countries were still endemic. Among these, Italy accounted for the second highest number of measles cases reported in Europe
Adamo, Giovanna   +9 more
core   +2 more sources

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries

open access: yesPapillomavirus Research, 2019
Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000.
Asmaa Gohar   +3 more
doaj   +1 more source

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda

open access: yesBMC Infectious Diseases, 2020
Background Control of Rubella and Congenital Rubella Syndrome using vaccination has shown great success in the America’s. Uganda is due to introduce the Rubella vaccine however the magnitude of transmission is not well documented.
Fred Bagenda   +4 more
doaj   +1 more source

Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. [PDF]

open access: yes, 2018
BACKGROUND: High rates of vaccination coverage are important in preventing infectious diseases. Enforcing mandatory vaccinations is one of the strategies that some Countries adopted to protect the community when vaccination coverage is not satisfactory ...
Bozzola E   +5 more
core   +2 more sources

Biological properties of domestic strain vRub-Ant of rubella virus

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2022
Introduction. Rubella is a mild infectious disease affecting mainly children and is caused by the rubella virus, part of the Matonoviridae family, genus Rubivirus.
Firaya G. Nagieva   +8 more
doaj   +1 more source

Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]

open access: yes, 2009
We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
A. BETT   +13 more
core   +2 more sources

Knowledge, attitude and behaviours towards recommended vaccinations among healthcare workers [PDF]

open access: yes, 2017
Healthcare workers (HCWs) are an important group of professionals exposed to biological risk during their work activities. So, the aim of this study is to perform a survey on the knowledge, attitude and behaviour of Italian HCWs towards the vaccinations ...
Chiarini, Massimiliano   +5 more
core   +2 more sources

Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.

open access: yesPLoS ONE, 2022
The Democratic Republic of the Congo (DRC) has a high measles incidence despite elimination efforts and has yet to introduce rubella vaccine. We evaluated the performance of a prototype rapid digital microfluidics powered (DMF) enzyme-linked immunoassay (
Alaine K Knipes   +29 more
doaj   +1 more source

Home - About - Disclaimer - Privacy